Liver Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 10.5 | Q1 | 93.5% | 3.334 | Q1 | 98.0% |
| 2024 | 9.1 | Q1 | 93.2% | 2.779 | Q1 | 97.3% |
| 2023 | 11.6 | Q1 | 91.7% | 3.599 | Q1 | 98.4% |
| 2022 | 13.8 | Q1 | 93.4% | 2.955 | Q1 | 97.9% |
| 2021 | 12.4 | Q1 | 90.3% | 2.062 | Q1 | 96.1% |
| 2020 | — | — | 1.916 | Q1 | 95.2% | |
| 2019 | — | — | 2.023 | Q1 | 95.7% | |
| 2018 | — | — | 1.845 | Q1 | 94.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1664-5553
ISSN
2235-1795
region
Western Europe
coverage
2009, 2012-2026